Cancer News and Research

Latest Cancer News and Research

Novelos Therapeutics acquires Cellectar

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has completed its acquisition of Cellectar, Inc., a Wisconsin-based drug development company, in a stock-for-stock transaction.

12 Apr 2011

Bowel cancer surgery survival rates “worrying” experts

In a new study that looked into post-operative death rates for one of the most common cancers, trends look worrying. On average 6.7% of patients died within a month of undergoing surgery for bowel cancer in England between 1998 and 2006. Patients face a seven-fold higher risk of dying after surgery in some NHS trusts than others, the study shows.

11 Apr 2011

Protest over planned cuts to Australian medical research funding

Australian medical researchers are protesting around the country following reports that funding to the sector could be cut in the May budget. The federal government is considering slashing $400 million from medical research.

11 Apr 2011

NCI awards MabVax with Phase II SBIR grant to develop vaccine against recurrent sarcoma

MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.

11 Apr 2011

GeoVax Labs expands its HIV/AIDS vaccine program with NIAID, NIH and HVTN

GeoVax Labs, Inc., announced today that it is expanding its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health and the HIV Vaccine Trials Network.

11 Apr 2011

Study shows how specific nutritional combination may help maintain healthy breast tissue

Researchers from Canada and the United States today told attendees of the Experimental Biology 2011 Scientific Meeting that they have uncovered a possible means of enabling women to favorably influence whether the estrogens in their bodies take a "beneficial path" or a "disease-potential" path.

11 Apr 2011

The Lancet publishes VIVUS 56-week QNEXA study results in obesity

VIVUS, Inc. today announced that detailed results from the 56-week CONQUER study were published in The Lancet evaluating the efficacy and safety of investigational drug QNEXA in 2,487 patients across 93 sites in the US.

11 Apr 2011

NBCAM events increase breast cancer diagnosis

Each October, the color pink marks the arrival of National Breast Cancer Awareness Month. Media coverage, product promotions and even the football gridirons showcase the national effort to promote screenings and early detection of the cancer that 200,000 American women are diagnosed with each year.

11 Apr 2011

Research on rare cancers

A cancer diagnosis can be a life-changing event. Many questions arise, with one of the first being, "Where should I be treated?" Patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer.

11 Apr 2011

CINJ experts to comment on vaccine therapy and biomedical informatics

April marks National Cancer Control Awareness Month, which focuses on the importance of prevention, treatment, and research. Making significant contributions in all of these areas is The Cancer Institute of New Jersey, one of the nation's 40 Comprehensive Cancer Centers as designated by the National Cancer Institute and the only such center in New Jersey.

11 Apr 2011

Budget agreement preserves funding for Planned Parenthood, Title X and the health law

President Obama and Democratic and Republican congressional leaders reached a last-minute deal Friday to avoid a government shutdown. The agreement, which came after days of partisan sparring and rhetorical drama, would fund the government through the end of September and cut $78.5 billion compared to Obama's proposed but never enacted fiscal 2011 budget.

11 Apr 2011

Synexus' Chief Medical Officer to discuss vaccine trial challenges at Washington event

Dr Glynis Neagle, Synexus' Chief Medical Officer will be discussing the challenges facing global vaccine trials at the World Vaccine Congress in Washington this week.

From AES - Accelerated Enrollment Solutions 11 Apr 2011

New experimental drug can help treat peripheral neuropathy in cancer patients

Although oncologists have made great strides in many aspects of cancer treatment, one area that has remained very difficult to treat is peripheral neuropathy, namely pain that can be caused by the cancer or by its treatment.

11 Apr 2011

Pfizer to support immatics' IMA901 Phase III trial in advanced renal cell carcinoma

immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that Pfizer has agreed to support its pivotal Phase III trial with IMA901, its therapeutic cancer vaccine for advanced renal cell carcinoma.

11 Apr 2011

Planned Parenthood funding a major stumbling block in budget negotiations

On the brink of a painful government shutdown, the Obama administration readied furlough notices for hundreds of thousands of workers Friday as Republican and Democratic leaders accused each other of refusing to give ground on a deal to keep operations running. ... Senate Majority Leader Harry Reid accused the Republicans of blocking a compromise because they were determined to make it harder 'for women to get cancer screenings' -- a Planned Parenthood funding reference.

11 Apr 2011

Annals of Neurology publishes Diamyd Medical´s NP2 Enkephalin Phase I results in cancer pain

Diamyd Medical´s Phase I clinical trial results evaluating the safety and efficacy of the candidate drug NP2 Enkephalin to treat intractable cancer pain has been published in the medical journal Annals of Neurology.

11 Apr 2011

Lonza, Roche sign agreement to commercialize MycoTOOL PCR-test

Roche and Lonza announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche's MycoTOOL mycoplasma PCR assays.

11 Apr 2011

Positive link between 100% fruit juice intake and reduced risk of chronic diseases

Drinking 100 percent fruit juices could have protective health benefits similar to those of whole fruits, according to research presented in a literature review yesterday at the 2011 Experimental Biology meeting.

11 Apr 2011

Childhood cancer survivors' cognitive problems linked to poor sleep and fatigue

A new analysis has found that childhood cancer survivors often suffer from sleep problems and fatigue, which negatively impact their attention and memory. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that addressing sleep hygiene among survivors of childhood cancer may help to improve their cognitive health.

11 Apr 2011

Gilenya can reduce risk of disability progression in patients with RRMS

A new analysis demonstrated that Gilenya reduced the risk of disability progression in patients with relapsing-remitting multiple sclerosis, regardless of treatment history. This analysis of the phase III two-year FREEDOMS study is one of 11 abstracts on Gilenya being presented at the 63rd annual meeting of the American Academy of Neurology.

11 Apr 2011

Cancer News and Research

Latest Cancer News and Research

Novelos Therapeutics acquires Cellectar

Bowel cancer surgery survival rates “worrying” experts

Protest over planned cuts to Australian medical research funding

NCI awards MabVax with Phase II SBIR grant to develop vaccine against recurrent sarcoma

GeoVax Labs expands its HIV/AIDS vaccine program with NIAID, NIH and HVTN

Study shows how specific nutritional combination may help maintain healthy breast tissue

The Lancet publishes VIVUS 56-week QNEXA study results in obesity

NBCAM events increase breast cancer diagnosis

Research on rare cancers

CINJ experts to comment on vaccine therapy and biomedical informatics

Budget agreement preserves funding for Planned Parenthood, Title X and the health law

Synexus' Chief Medical Officer to discuss vaccine trial challenges at Washington event

New experimental drug can help treat peripheral neuropathy in cancer patients

Pfizer to support immatics' IMA901 Phase III trial in advanced renal cell carcinoma

Planned Parenthood funding a major stumbling block in budget negotiations

Annals of Neurology publishes Diamyd Medical´s NP2 Enkephalin Phase I results in cancer pain

Lonza, Roche sign agreement to commercialize MycoTOOL PCR-test

Positive link between 100% fruit juice intake and reduced risk of chronic diseases

Childhood cancer survivors' cognitive problems linked to poor sleep and fatigue

Gilenya can reduce risk of disability progression in patients with RRMS

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in